Evaluating treatments and outcomes for Canadians with cancer: this research provides insight into how the quality of cancer care can be improved, and whether patients in Canada are achieving the best possible outcomes.Â
¾ÅÐãÖ±²¥ researcher Michael Brundage discusses his research on quality of life which he undertakes as part of the Canadian Cancer Trials Group and the ¾ÅÐãÖ±²¥ Cancer Research Institute.
¾ÅÐãÖ±²¥ researcher with the ¾ÅÐãÖ±²¥ Cancer Research Institute, Annette Hay discusses her research on clinical trials and Ontario’s Institute for Clinical Evaluative Sciences (ICES).
¾ÅÐãÖ±²¥ cancer research Jim Biagi will lead a promising international trial that could introduce a new chemotherapy regimen to improve the survival rate of patients undergoing surgery for gastrointestinal and gynaecological cancers.
¾ÅÐãÖ±²¥ researcher David Berman is dedicated to unravelling the challenges of dealing with prostate cancer through his work with ¾ÅÐãÖ±²¥ Cancer Research Institute and the Canadian Cancer Trials Group.